Soo-Chin Lee (Yiqing Huang)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Tyrosine Kinase

Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Top Venues

Thoracic cancer

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Soo-Chin Lee, Joseph J Zhao, Yu Yang Soon, Adrian Kee, Sen Hee Tay, Folefac Aminkeng, Yvonne Ang, Alvin S C Wong, Lavina D Bharwani, Boon Cher Goh, Ross A Soo
Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer. Cancers 15 (10) (2023)
Soo-Chin Lee, Joseph J Zhao, Yu Yang Soon, Alvin Wong, Folefac Aminkeng, Yvonne Ang, Yugarajah Asokumaran, Jia Li Low, Matilda Lee, Joan R E Choo, Gloria Chan, Adrian Kee, Sen Hee Tay, Boon Cher Goh, Ross A Soo
Real-world experience of consolidation durvalumab after concurrent chemoradiotherapy in stage III non-small cell lung cancer. Thoracic cancer 13 (22) (2022)
Jenny Hui Ling Chieng, Zaw Win Htet, Joseph J Zhao, E Shyong Tai, Sen Hee Tay, Soo-Chin Lee, Alvin S C Wong, Samantha Peiling Yang
Clinical Presentation of Immune-Related Endocrine Adverse Events during Immune Checkpoint Inhibitor Treatment. Cancers 14 (11) (2022)
Soo-Chin Lee, Yu Yang Soon, Folefac Aminkeng, Sen Hee Tay, Yvonne Ang, Adrian C L Kee, Boon Cher Goh, Alvin S C Wong, Ross A Soo
Risk factors for immune-related adverse events from anti-PD-1 or anti-PD-L1 treatment in an Asian cohort of nonsmall cell lung cancer patients. International journal of cancer (2021)
Yvonne L E Ang, Gwo Fuang Ho, Ross A Soo, Raghav Sundar, Sing Huang Tan, Wei Peng Yong, Samuel G W Ow, Joline S J Lim, Wan Qin Chong, Phyu Pyar Soe, Bee Choo Tai, Lingzhi Wang, Boon Cher Goh, Soo-Chin Lee
A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours. BMC cancer 20 (1) (2020)